BioPower Operations Corporation (BOPO) fair value: what the stock is really worth
As of Sep 30, 2026: fair value (intrinsic value) of BioPower Operations Corporation stock $0.01, price $0.01, upside +2.0%, quality 62 out of 100. Rating: fairly valued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 21, 2026.
How to read this chart
60‑month range $0.0001 – $0.9100 · fair‑value band $0.0099 – $0.0104 · the $0.0100 price screens below the $0.0102 fair value. Dashed = 300-day average. As of Oct 21, 2026.
Follow BioPower Operations in your weekly email
Every Wednesday you see whether BioPower Operations is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
BioPower Operations Corporation, through its subsidiaries, operates as a renewable energy company. The company engages in the mobilization of projects, project funding solutions, and project technology deliverables to develop and help finance their construction.
Show moreShow less
It also offers other consultancy services in the green energy, environmental and infrastructure market. BioPower Operations Corporation was incorporated in 2010 and is based in Aventura, Florida.
Stock analysis
BioPower Operations Corporation (BOPO) currently trades at $0.0100, while our model-based Fair Value estimate is $0.0102, so the stock looks roughly fairly valued today (gap 2.0%).
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $0.0900 per share, and 5 of the 6 models we run sit above the $0.0100 price.
Bear case: the Multiples group reads lowest at $0.0100, and 1 of the 6 models stay below the price. Data coverage for this calculation is low.
Scenario range: $0.0099 (bear) to $0.0104 (bull), the price of $0.0100 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 62/100 (solid quality), in the Financial Services sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
BioPower Operations Corporation reported revenue of $572K in FY2023 versus $0 in FY2019. Reported net income was −$793K in FY2023.
Key figures
Market cap $453K Micro · P/S ratio 3.80 · EPS (TTM) $−14.00 · Net margin −139% · Return on assets (EBIT) −2,853% · Operating margin −4,682% · Revenue growth (YoY) +15.0% · Free cash flow $306K.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (low confidence).
What moves the price
For context, the median of 10 Financial Services peers we cover trades at −19% fair-value upside, at 2%, BOPO screens cheaper than that median.
Fair Value models
Bear$0.0099Fair Value $0.0102Bull$0.0104
Price $0.0100 · Upside +2.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.22/100
Revenue growth is weak, negative or inconsistent.
Revenue growth 1 year
+0.0%
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.3%
’13
’14
’15
’21
’22
’23
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−503.1% (2013) → −103.5% (2023)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2023 is a loss year, no rate is defined from a loss
Compare BioPower Operations Corporation with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Shell Companies · 60 stocks
Beats the industry median on 4/6 measures
Overall it ranks above its industry peers.
Valuation
Quality Score62 · Above median
Fair Value upside+2.0% · Above median
Profitability
Return on equity (12 months)Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Net margin (12 months)−138.6% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)15.0% · Top 25%
Balance sheet
Debt / equityNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Valuation Multiplesvs Shell Companies median · lower = cheaper
P/BNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months)3.62× · Pricier than median
Price / free cash flow1.5× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)36· sector 26
FUTURE (revenue growth)75· sector 0
PAST (return on equity)0· sector 0
HEALTH (low debt)0· sector 100
DIVIDEND (yield)0· sector 0
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is BioPower Operations Corporation (BOPO) overvalued or undervalued?
As of Oct 21, 2026, our model estimates a fair value of $0.0102 versus the last price from Sep 30, 2026 of $0.0100, about +2% upside (fairly valued).
What is the fair value of BOPO?
Our model-based fair value for BioPower Operations Corporation is $0.0102 (as of Oct 21, 2026), built from audited fundamentals. Last price (from Sep 30, 2026): $0.0100.
What is the quality score of BOPO?
BioPower Operations Corporation has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for BioPower Operations Corporation (BOPO)?
Our model-based price target is the fair value of $0.0102 (as of Oct 21, 2026) from 6 valuation models. Cautious scenario $0.0099, optimistic scenario $0.0104. It is a calculation from audited fundamentals, not an analyst target.
What is the BioPower Operations Corporation stock forecast for 2026?
Our models put fair value at $0.0102, about +2% upside versus the last price from Sep 30, 2026 of $0.0100 (fairly valued). Cautious scenario $0.0099, optimistic scenario $0.0104. The calculation is refreshed regularly with new filings.
What is the intrinsic value of BioPower Operations Corporation (BOPO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For BioPower Operations Corporation it is $0.0102 per share (as of Oct 21, 2026), against a price of $0.0100. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is BioPower Operations Corporation stock overvalued or undervalued in 2026?
As of Oct 21, 2026, BOPO trades below its calculated fair value: price $0.0100, fair value $0.0102, a gap of about +2% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BOPO?
No. The price is what the market pays today ($0.0100); the fair value is what the company's own numbers justify ($0.0102). For BioPower Operations Corporation the two are $0.0002 per share apart. That gap is exactly why we show both numbers side by side.
How much is BioPower Operations Corporation worth?
The market values BioPower Operations Corporation at about $453K (market capitalisation, as of Oct 21, 2026). Per share that is $0.0100; our models calculate a fair value of $0.0102 per share.
What do the bullish and bearish scenarios say about BOPO?
Our models span a range for BioPower Operations Corporation: cautious scenario $0.0099, base $0.0102, optimistic $0.0104 per share (as of Oct 21, 2026, price $0.0100). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of BioPower Operations Corporation (BOPO)?
Balance-sheet figures for BioPower Operations Corporation (as of Oct 21, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
Which stocks are comparable to BioPower Operations Corporation?
From the same area (Financial Services) we also value Lionheart III Corp, AA Mission Acquisition Corp, Berto Acquisition Corp, Axiom Intelligence Acquisition Corp, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is BioPower Operations Corporation stock attractive at the current price?
The data as of Oct 21, 2026: price $0.0100, calculated fair value $0.0102 (+2%), Quality Score 62/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BOPO calculated?
We run BioPower Operations Corporation through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0102, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6 % above its aggregate fair value. BioPower Operations Corporation currently trades 2 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of BioPower Operations Corporation (BOPO)?
The latest price we hold is from Sep 30, 2026 and stands at $0.0100. Our model-based fair value is $0.0102, about +2% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with BioPower Operations Corporation right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The models converge in a tight band ($0.0099 to $0.0104), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of BioPower Operations Corporation
How large is the market capitalisation of BioPower Operations Corporation (BOPO)?
The market capitalisation of BioPower Operations Corporation is $453K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of BioPower Operations Corporation (BOPO)?
The price-to-sales ratio of BioPower Operations Corporation is 3.80 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of BioPower Operations Corporation (BOPO)?
Earnings per share at BioPower Operations Corporation are $−14.00. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of BioPower Operations Corporation (BOPO)?
The net margin of BioPower Operations Corporation is −139% (fiscal year 2023). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of BioPower Operations Corporation (BOPO)?
On an EBIT basis the return on assets of BioPower Operations Corporation is −2,853% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of BioPower Operations Corporation (BOPO)?
The operating margin of BioPower Operations Corporation is −4,682% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at BioPower Operations Corporation (BOPO)?
Revenue at BioPower Operations Corporation is growing +15.0% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does BioPower Operations Corporation (BOPO) generate?
The free cash flow of BioPower Operations Corporation is $306K (fiscal year 2023). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does BioPower Operations Corporation (BOPO) carry?
The net debt of BioPower Operations Corporation is $2.6M (fiscal year 2023, ≈ 8.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch BioPower Operations Corporation in the live analysis
One click puts BioPower Operations Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 21, 2026